Practical Approaches to Immunotherapy in the Clinic-Reference-Cited by-同舟云学术

Practical Approaches to Immunotherapy in the Clinic

Published:2015-12 Issue: Volume:42 Page:S20-S27
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Agarwala Sanjiv S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference30 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

3. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

4. NCCN Clinical Practice Guidelines in Oncology. Melanoma. Version 3.2015. Available at: http://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf. Accessed on July 23, 2015.

5. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomized dose-comparison cohort of a phase 1 trial;Robert;Lancet,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological drug and drug delivery-mediated immunotherapy;Acta Pharmaceutica Sinica B;2021-04

2. Different responses to anti‑programmed cell death protein 1 (PD‑1) immunotherapy in a patient with Lynch syndrome and metachronous urothelial and colon cancer: A case report;Oncology Letters;2019-09-23

3. Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations;Frontiers in Pharmacology;2019-07-02

4. Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors;Oncotarget;2017-03-17

5. High-risk Cutaneous Squamous Cell Carcinoma;International Journal of Head and Neck Surgery;2017